Skip to main content

OCULAR THERAPEUTIX, INC insider trading

OCULNASDAQ
$6.96-0.33 (-4.53%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-37.1%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • PDPravin DugelSee Remarks1.4891%of company
  • DNDonald NotmanChief Operating Officer0.1669%of company
  • SNSanjay NayakChief Strategy Officer0.1489%of company
  • JSJeffrey S. HeierChief Scientific Officer0.1449%of company
  • NWNadia WaheedChief Medical Officer0.1366%of company
  • PKPeter KaiserChief Development Officer0.1204%of company
  • RLRichard L. Lindstrom M.D.Director0.1188%of company
  • NSNamrata SarojChief Business Officer0.1159%of company
  • SLSteve Lawrence MeyersChief Commercial Officer0.0991%of company
  • TATodd AndermanChief Legal Officer0.0694%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
OCULDonald NotmanChief Operating OfficerOpen market sell$11.3K-0.3%$10.24$11.3KAug 31, 2026Sep 2, 2026
OCULPeter KaiserChief Development OfficerOpen market sell$32.7K-1.1%$10.77$32.7KAug 24, 2026Aug 26, 2026
OCULSanjay NayakChief Strategy OfficerOpen market sell$20.4K-0.6%$10.78$20.4KAug 24, 2026Aug 26, 2026
OCULJeffrey S. HeierChief Scientific OfficerOpen market sell$35.5K-1.0%$10.78$35.5KAug 24, 2026Aug 26, 2026
OCULPravin DugelSee RemarksOpen market sell$233K-0.7%$10.77$233KAug 24, 2026Aug 26, 2026
OCULNadia WaheedChief Medical OfficerOpen market sell$123K-4.7%$8.27$123KJun 3, 2026Jun 5, 2026
OCULPravin DugelSee RemarksOpen market sell$173K-0.6%$8.20$173KMay 26, 2026May 28, 2026
OCULPeter KaiserChief Development OfficerOpen market sell$24.3K-1.1%$8.20$24.3KMay 26, 2026May 28, 2026
OCULJeffrey S. HeierChief Scientific OfficerOpen market sell$24.7K-0.9%$8.20$24.7KMay 26, 2026May 28, 2026
OCULSanjay NayakChief Strategy OfficerOpen market sell$15.2K-0.6%$8.20$15.2KMay 26, 2026May 28, 2026
OCULPravin DugelSee RemarksOpen market sell$166K-0.6%$8.28$166KFeb 23, 2026Feb 25, 2026
OCULPeter KaiserChief Development OfficerOpen market sell$23.3K-1.0%$8.28$23.3KFeb 23, 2026Feb 25, 2026
OCULJeffrey S. HeierChief Scientific OfficerOpen market sell$25.3K-0.9%$8.28$25.3KFeb 23, 2026Feb 25, 2026
OCULSanjay NayakChief Strategy OfficerOpen market sell$14.6K-0.5%$8.28$14.6KFeb 23, 2026Feb 25, 2026
OCULNadia WaheedChief Medical OfficerOpen market sell$27.2K-1.1%$7.74$27.2KFeb 20, 2026Feb 24, 2026
OCULRichard L. Lindstrom M.D.DirectorOpen market purchase$461K+32.3%$7.66$461KFeb 20, 2026Feb 24, 2026
OCULDonald NotmanChief Operating OfficerOpen market sell$103K-3.0%$9.04$103KFeb 12, 2026Feb 17, 2026
OCULSanjay NayakChief Strategy OfficerOpen market sell$93.5K-3.0%$9.04$93.5KFeb 12, 2026Feb 17, 2026
OCULPravin DugelSee RemarksOpen market sell$1.13M-3.6%$9.04$1.13MFeb 12, 2026Feb 17, 2026
OCULNadia WaheedChief Medical OfficerOpen market sell$71.1K-2.4%$9.04$71.1KFeb 12, 2026Feb 17, 2026
OCULDonald NotmanChief Operating OfficerOpen market sell$51.5K-1.6%$8.54$51.5KFeb 4, 2026Feb 4, 2026
OCULDonald NotmanChief Operating OfficerOpen market sell$49.9K-1.4%$9.14$49.9KFeb 2, 2026Feb 4, 2026
OCULSanjay NayakChief Strategy OfficerOpen market sell$22.6K-0.7%$12.04$22.6KNov 24, 2025Nov 26, 2025
OCULPravin DugelSee RemarksOpen market sell$235K-0.6%$12.04$235KNov 24, 2025Nov 26, 2025
OCULPeter KaiserChief Development OfficerOpen market sell$36.1K-1.6%$12.02$36.1KNov 24, 2025Nov 26, 2025
OCULJeffrey S. HeierChief Scientific OfficerOpen market sell$41.8K-1.4%$12.04$41.8KNov 24, 2025Nov 26, 2025
OCULNamrata SarojChief Business OfficerOpen market sell$278K-12.9%$10.74$278KNov 5, 2025Nov 7, 2025
OCULTodd AndermanChief Legal OfficerOpen market sell$137K-11.3%$12.34$137KOct 8, 2025Oct 10, 2025
End of history · 28 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.